Coherus Oncology, Inc. · NASDAQ:CHRS
Thomas A. Satterfield, Jr. reported a 5.20% stake in Coherus Oncology, Inc. (Schedule 13G)
Event Apr 14, 2025 · Filed Apr 16, 2025
Thomas A. Satterfield, Jr. reported a 5.20% stake in Coherus Oncology, Inc., 6,009,514 shares, as a passive investor on Apr 14, 2025. Filed Apr 16, 2025 (Schedule 13G).
- Stake
- 5.20%
- Shares
- 6,009,514
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Thomas A. Satterfield, Jr. | 5.20% | 6,009,514 |
Source
Related
- Coherus Oncology, Inc.
- Thomas A. Satterfield, Jr.
- Coherus Oncology, Inc. shareholders
- Schedule 13G/A · Thomas A. Satterfield, Jr. · Apr 29, 2026
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Satvat Ali J. · Jun 9, 2026
- Form 4 · Karachun Rita A · Jun 9, 2026
- Form 4 · Newcomer Lee Nisley · Jun 9, 2026
- Form 4 · Ryan Michael Lee · Jun 9, 2026